VITAE PHARMACEUTICALS, INC (VTAE) financial statements (2021 and earlier)

Company profile

Business Address 502 WEST OFFICE CENTER DR
FORT WASHINGTON, PA 19034
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:5965
Cash and cash equivalents1229
Short-term investments4836
Other undisclosed cash, cash equivalents, and short-term investments0(0)
Deferred costs 0
Other undisclosed current assets21
Total current assets:6167
Noncurrent Assets
Property, plant and equipment10
Restricted cash and investments00
Deferred costs 0
Total noncurrent assets:11
TOTAL ASSETS:6268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities76
Accounts payable31
Accrued liabilities43
Employee-related liabilities 2
Interest and dividends payable 0
Debt 5
Other undisclosed current liabilities (2)
Total current liabilities:79
Noncurrent Liabilities
Liabilities, other than long-term debt 0
Deferred revenue and credits 0
Other undisclosed noncurrent liabilities0 
Total noncurrent liabilities:00
Total liabilities:79
Stockholders' equity
Stockholders' equity attributable to parent, including:5459
Common stock 0
Treasury stock, value(0) 
Additional paid in capital228189
Accumulated other comprehensive loss(0)(0)
Accumulated deficit(174)(130)
Other undisclosed stockholders' equity attributable to parent0 
Total stockholders' equity:5459
TOTAL LIABILITIES AND EQUITY:6268

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
Gross profit:19
Operating expenses(45)(27)
Operating loss:(44)(19)
Nonoperating income (expense)0(1)
Investment income, nonoperating00
Other nonoperating income00
Interest and debt expense(0)(1)
Net loss:(44)(20)
Other undisclosed net income attributable to parent01
Net loss available to common stockholders, diluted:(44)(19)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
Net loss:(44)(20)
Comprehensive loss:(44)(20)
Other undisclosed comprehensive income, net of tax, attributable to parent01
Comprehensive loss, net of tax, attributable to parent:(44)(19)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: